In the pharmaceutical industry, roxithromycin has emerged as a widely prescribed macrolide antibiotic used to treat various bacterial infections, including respiratory tract, skin, and soft tissue infections. With its increasing demand in both developed and emerging markets, understanding the production costs of roxithromycin is vital for pharmaceutical companies and stakeholders aiming to maintain competitiveness and …